AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 1 217-R224, Copyright © 1991 by American Physiological Society

ARTICLES

Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans

N. E. Bruun, P. Skott and J. Giese
Department of Clinical Physiology and Nuclear Medicine, Glostrup University Hospital, Denmark.

The renal and endocrine effects of incremental infusions of 3 and 6 ng.kg-1.min-1 of exogenous atrial natriuretic factor (ANF)-(99-126) or placebo were investigated in 10 normal subjects. A 90-min basal period was followed by two 2-h infusion periods with urine collection in the last 90 min of each period. Plasma ANF concentration increased by 50 and 150%, respectively, from a basal value of 6.2 +/- 3.1 pmol/l. Plasma guanosine 3',5'-cyclic monophosphate concentration increased in parallel with ANF. Blood pressure and heart rate were unchanged, whereas hematocrit was stepwise increased. 51Cr-EDTA clearance (GFR) did not change, but ANF caused an increase in Li clearance (a measure of end-proximal fluid delivery), Na clearance, and urine flow compared with time-matched control values. These excretory effects of ANF were mainly due to prevention of the 20- to 50% decreases occurring in the placebo series. Calculated values of fractional proximal and distal tubular Na reabsorption decreased significantly. ANF caused a decrease in plasma concentrations of active renin and aldosterone, whereas renin substrate, angiotensin I, and angiotensin II concentrations were unaltered. A subtle increase in plasma concentrations of norepinephrine and epinephrine was observed during the ANF infusions. These data suggest that the natriuretic effect of ANF is caused by an increased fluid delivery from the proximal tubule in addition to a fall in fractional distal Na reabsorption.

This article has been cited by other articles:

				V. Tervonen, H. Ruskoaho, T. Lecklin, M. Ilves, and O. Vuolteenaho Salmon cardiac natriuretic peptide is a volume-regulating hormone Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E353 - E361. [Abstract] [Full Text] [PDF]

				J. L. Andersen, N. C. F. Sandgaard, and P. Bie Volume expansion during acute angiotensin II receptor (AT1) blockade and NOS inhibition in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1140 - R1148. [Abstract] [Full Text] [PDF]

				J. L. Andersen, N. C. F. Sandgaard, and P. Bie Volume expansion during NOS substrate donation with L-arginine: regulatory offsetting of renal response? Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1149 - R1155. [Abstract] [Full Text] [PDF]

				J. L. Andersen, L. J. Andersen, N. C. F. Sandgaard, and P. Bie Volume expansion natriuresis during servo control of systemic blood pressure in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R19 - R27. [Abstract] [Full Text] [PDF]

				M. H. Bestle, N. V. Olsen, P. Christensen, B. V. Jensen, and P. Bie Cardiovascular, endocrine, and renal effects of urodilatin in normal humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R684 - R695. [Abstract] [Full Text] [PDF]

				G. Barletta, C. Lazzeri, S. Vecchiarino, R. Del Bene, G. Messeri, A. Dello Sbarba, M. Mannelli, and G. La Villa Low-Dose C-Type Natriuretic Peptide Does Not Affect Cardiac and Renal Function in Humans Hypertension, March 1, 1998; 31(3): 802 - 808. [Abstract] [Full Text] [PDF]

				G. La Villa, L. Stefani, C. Lazzeri, C. Zurli, C. T. Guerra, G. Barletta, R. Bandinelli, G. Strazzulla, and F. Franchi Acute Effects of Physiological Increments of Brain Natriuretic Peptide in Humans Hypertension, October 1, 1995; 26(4): 628 - 633. [Abstract] [Full Text]